No Red Envelopes As MRs Granted New China Recognition
This article was originally published in PharmAsia News
Executive Summary
The exchange of red envelopes containing gifts or money, considered customary during the Lunar New Year celebrations in China, is becoming an outdated practice as far as medical reps and physicians go, amid ever-increasing ethical scrutiny and government efforts to restore the reputation of a tarnished profession.
You may also be interested in...
China Imposes Tough New Curbs On Rep Sales Activities
Tough new rules from China’s State Council have put the country’s one million medical reps into limbo as their employers scrabble to get to grips with broad curbs on sales activities.
2016 Review: Pricing, R&D Issues Dominate China Commercial Arena
2016 was again another busy year on the commercial front in China, with market changes, new regulations, and ongoing pricing pressures all affecting the pharma sector. Meanwhile, the push for licensing deals, innovation, and international expansion continued apace.
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues.